|
Real-time Estimate
Cboe BZX
13:17:26 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 9.090 USD | +2.48% |
|
-16.91% | -22.52% |
Company Valuation: Sutro Biopharma, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 688.5 | 464.4 | 261.5 | 151.7 | 98.57 | 147.1 | - | - |
| Change | - | -32.55% | -43.69% | -41.98% | -35.03% | 49.21% | - | - |
| Enterprise Value (EV) | 552 | 179.6 | 196.3 | -38.58 | -42.86 | 147.1 | 147.1 | 147.1 |
| Change | - | -67.46% | 9.29% | -119.66% | -11.09% | 443.16% | 0% | 0% |
| P/E | -6.5x | -3.44x | -2.41x | -0.62x | -0.51x | -1.08x | -1.34x | -1.36x |
| PBR | - | - | 1.75x | 3.4x | -7.5x | - | - | - |
| PEG | - | -1.31x | 0.1x | -0x | 0x | 0x | 0.1x | 1.42x |
| Capitalization / Revenue | 11.1x | 6.85x | 1.7x | 2.45x | 0.96x | 2.85x | 4.65x | 5.78x |
| EV / Revenue | 0x | 0x | 0x | -0x | -0x | 2.85x | 4.65x | 5.78x |
| EV / EBITDA | -0x | -0x | - | 0x | 0x | -1.48x | -1.38x | -1.13x |
| EV / EBIT | -0x | -0x | -0x | 0x | 0x | -1.3x | -1.22x | -0.98x |
| EV / FCF | -0x | -0x | -0x | 0x | 0x | -1.46x | -1.33x | -0.96x |
| FCF Yield | -14.1% | -0.93% | -44.3% | -128% | -182% | -68.5% | -75% | -104% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -22.9 | -23.5 | -17.8 | -29.6 | -22.49 | -8.23 | -6.608 | -6.544 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 61.88 | 67.77 | 153.7 | 62.04 | 102.5 | 51.55 | 31.6 | 25.44 |
| EBITDA 1 | -93.68 | -123.3 | - | -231.2 | -97.63 | -99.51 | -106.8 | -130.4 |
| EBIT 1 | -98.52 | -128.9 | -89.28 | -238.5 | -105 | -113.3 | -120.3 | -150.1 |
| Net income 1 | -105.5 | -119.2 | -106.8 | -227.5 | -191.1 | -129.5 | -140.7 | -153.5 |
| Net Debt | -136.5 | -284.8 | -65.21 | -190.3 | -141.4 | - | - | - |
| Reference price 2 | 148.800 | 80.800 | 42.900 | 18.400 | 11.570 | 8.870 | 8.870 | 8.870 |
| Nbr of stocks (in thousands) | 4,627 | 5,748 | 6,095 | 8,246 | 8,519 | 16,581 | - | - |
| Announcement Date | 2/28/22 | 3/30/23 | 3/25/24 | 3/13/25 | 3/23/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.08x | - | - | -.--% | 147M | |
| 17.08x | 6.33x | 12.4x | 1.75% | 63.48B | |
| 30.03x | 7.96x | 26.08x | 0.05% | 54.55B | |
| 37.03x | 6.57x | 19.63x | 0.87% | 53.59B | |
| 35.05x | 3.37x | 14.55x | -.--% | 44.75B | |
| 48.28x | 5.55x | 30.42x | -.--% | 41.62B | |
| -19.33x | 186.93x | -20.57x | -.--% | 39.91B | |
| 30.28x | 7.94x | 20.6x | 0.4% | 32.47B | |
| 36.51x | 6.64x | 22.27x | -.--% | 26.7B | |
| 26.96x | 5.67x | 14.71x | -.--% | 23.36B | |
| Average | 24.08x | 26.33x | 15.57x | 0.31% | 38.06B | |
| Weighted average by Cap. | 26.54x | 25.23x | 15.68x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- STRO Stock
- Valuation Sutro Biopharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
